599
Views
16
CrossRef citations to date
0
Altmetric
Articles

Fear of cancer recurrence and associations with mental health status and individual characteristics among cancer survivors: Findings from a nationally representative sample

, MSW, MPH, PhDORCID Icon, , PhD, MPH, MN, , PhD, , MD, MPH, , MD, MPH & , MD, PhD, MPH

References

  • Zhao G, Okoro CA, Li J, et al. Current depression among adult cancer survivors: findings from the 2010 Behavioral Risk Factor Surveillance System. Cancer Epidemiol. 2014;38(6):757–764. doi:10.1016/j.canep.2014.10.002
  • Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (>/= 5 years) cancer survivors – a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11. doi:10.1002/pon.3022
  • Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–322. doi:10.1007/s11764-013-0272-z
  • Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv. 2010;4(4):361–371. doi:10.1007/s11764-010-0136-8
  • Lee-Jones C, Humphris G, Dixon R, et al. Fear of cancer recurrence – a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95–105. doi:10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B
  • Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265–3268. doi:10.1007/s00520-016-3272-5
  • Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology. 2009;18(6):580–588. doi:10.1002/pon.1437
  • Humphris GM, Rogers S, McNally D, et al. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32(5):486–491.
  • Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47(4):340–347. doi:10.1176/appi.psy.47.4.340
  • Matulonis UA, Kornblith A, Lee H, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183–1193. doi:10.1111/j.1525-1438.2007.01167.x
  • Medical Expenditure Panel Survey. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
  • Agency for Healthcare Research and Quality CfF, Access, and Cost Trends: MEPS HC-147 2011 Full Year Consolidated Data File, September 2013.
  • McCabe MS, Bhatia S, Oeffinger KC, et al. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631–640. doi:10.1200/JCO.2012.46.6854
  • Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Quart. 2005;83(4):95–124. doi:10.1111/j.1468-0009.2005.00428.x
  • Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav.1995;36(1):1–10. doi:10.2307/2137284
  • Arora NK, Hamilton AS, Potosky AL, et al. Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv. 2007;1(1):49–63. doi:10.1007/s11764-007-0004-3
  • Ganz PA, Land SR, Antonio C, et al. Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group. J Cancer Surviv. 2009;3(3):137–147. doi:10.1007/s11764-009-0093-2
  • Palmer NR, Geiger AM, Felder TM, et al. Racial/ethnic disparities in health care receipt among male cancer survivors. Am J Public Health. 2013;103(7):1306–1313. doi:10.2105/AJPH.2012.301096
  • Virgo KS, Lerro CC, Klabunde CN, et al. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol. 2013;31(18):2322–2336. doi:10.1200/JCO.2012.45.6954
  • Thewes B, Butow P, Zachariae R, et al. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology 2012;21(6):571–587.
  • Bayliss EA, Ellis JL, Shoup JA, et al. Association of patient-centered outcomes with patient-reported and ICD-9-based morbidity measures. Ann Fam Med. 2012;10(2):126–133. doi:10.1370/afm.1364
  • Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348–353. doi:10.1370/afm.1139
  • Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–976.
  • Harvard Medical School: K10 and K6 Scales; 2005.
  • Fleishman JA. Methodology Report #15: Demographic and Clinical Variations in Health Status, U. S. Department of Health and Human Services Public Health Service Agency for Healthcare Research and Quality; 2005.
  • Vilagut G, Forero CG, Pinto-Meza A, et al. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods. Value Health. 2013;16(4):564–573. doi:10.1016/j.jval.2013.01.006
  • Bohmer MM, Brandl M, Brandstetter S, et al. Factors associated with generic health-related quality of life in adult asthma patients in Germany: cross-sectional study. J Asthma. 2016;54(3):325–334.
  • Busija L, Pausenberger E, Haines TP, et al. Adult measures of general health and health-related quality of life: medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care Res. 2011;63(Suppl. 11):S383–S412. doi:10.1002/acr.20541
  • Kao CW, Chen MY, Chen TY, et al. Effect of psycho-educational interventions on quality of life in patients with implantable cardioverter defibrillators: a meta-analysis of randomized controlled trials. Health Qual Life Outcomes. 2016;14(1):138. doi:10.1186/s12955-016-0543-2
  • Dieng M, Butow PN, Costa DSJ, et al. Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. J Clin Oncol. 2016;34(36):4405. doi:10.1200/JCO.2016.34.15_suppl.10068
  • Butow PN, Bell ML, Smith AB, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. 2013;13:201. doi:10.1186/1471-2407-13-201
  • Humphris G, Ozakinci G. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J Health Psychol. 2008;13(Pt 2):223–230. doi:10.1348/135910708X283751
  • Maheu C, Lebel S, Courbasson C, et al. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer. BMC Cancer. 2016;16:291. doi:10.1186/s12885-016-2326-x
  • Butow PN, Turner J, Gilchrist J, et al. Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. J Clin Oncol. 2017;35(36):4066–4077. doi:10.1200/JCO.2017.73.1257
  • van de Wal M, Thewes B, Gielissen M, et al. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. 2017;35(19):2173–2183. doi:10.1200/JCO.2016.70.5301
  • Anja M, Angela dB, Michael F. Employment challenges for cancer survivors. Cancer. 2013;119:2151–2159.
  • Warner EL, Nam GE, Zhang Y, et al. Health behaviors, quality of life, and psychosocial health among survivors of adolescent and young adult cancers. J Cancer Surviv. 2016;10(2):280–290. doi:10.1007/s11764-015-0474-7
  • Tm J, Johan B, Jolanda DV, et al. Sexual, marital, and general life functioning in couples coping with colorectal cancer: a dyadic study across time. Psycho-Oncology. 2015;24:1181–1188.
  • Gill SC, Butterworth P, Rodgers B, et al. Validity of the mental health component scale of the 12-item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population. Psychiatry Res. 2007;152(1):63–71. doi:10.1016/j.psychres.2006.11.005
  • Fardell JE, Thewes B, Turner J, et al. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016;10(4):663–673. doi:10.1007/s11764-015-0512-5
  • Lebel S, Ozakinci G, Humphris G, et al. Current state and future prospects of research on fear of cancer recurrence. Psychooncology. 2017;26(4):424–427. doi:10.1002/pon.4103
  • Lebel S, Simard S, Harris C, et al. Empirical validation of the English version of the Fear of Cancer Recurrence Inventory. Qual Life Res. 2016;25(2):311–321. doi:10.1007/s11136-015-1088-2
  • Fardell JE, Jones G, Smith AB, et al. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence. Psychooncology. 2018;27(2):492–499. doi:10.1002/pon.4516
  • van de Wal M, van de Poll-Franse L, Prins J, et al. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry. Psychooncology. 2016;25(7):772–778.
  • Thewes B, Butow P, Bell ML, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012;20(11):2651–2659. doi:10.1007/s00520-011-1371-x
  • Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013;22(5):978–986. doi:10.1002/pon.3114
  • Mehta SS, Lubeck D, Pasta DJ, et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol. 2003;170(5):1931–1933. doi:10.1097/01.ju.0000091993.73842.9b
  • Ruane-McAteer E, Porter S, O'Sullivan JM, et al. Active surveillance for favorable-risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review. Psychooncology. 2017;26(10):1411–1421.
  • Rittenmeyer L, Huffman D, Alagna M, et al. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review. JBI Database Syst Rev Implement Rep. 2016;14(2):174–255. doi:10.11124/jbisrir-2016-2270

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.